Mediprop Limited - Filleted accounts

Registered number

03936370

Mediprop Limited

Abbreviated Accounts

28 February 2025

Mediprop Limited
Registered number:		03936370
Balance Sheet
as at 28 February 2025

Notes			2025			2024
£				£
Fixed assets
Tangible assets	3		16,873			9,445

Current assets
Stocks		7,595			3,595
Debtors	4	-			-
Cash at bank and in hand		1,247			1,247
		8,842			4,842

Creditors: amounts falling due within one year	5	(28,167)			(19,898)

Net current liabilities			(19,325)			(15,056)

Net liabilities			(2,452)			(5,611)

Capital and reserves
Called up share capital			100			100
Profit and loss account			(2,552)			(5,711)

Shareholders' funds			(2,452)			(5,611)

The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.




J Carter
Director
Approved by the board on 29 November 2025

Mediprop Limited
Notes to the Accounts
for the year ended 28 February 2025


1	Accounting policies

	Tangible fixed assets
	Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:

	Freehold buildings	over 50 years
	Leasehold land and buildings	over the lease term
	Plant and machinery	over 5 years
	Fixtures, fittings, tools and equipment	over 5 years

	Investments
	Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.

	Stocks
	Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first in first out method. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised.

	Debtors
	Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.

	Creditors
	Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.

	Taxation
	A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.


2	Employees		2025		2024
Number				Number

	Average number of persons employed by the company		1		1


3	Tangible fixed assets
					Plant and machinery etc
£
	Cost
	At 29 February 2024				182,950
	At 28 February 2025				194,596

	Depreciation
	At 29 February 2024				173,505
	Charge for the year				4,218
	At 28 February 2025				177,723

	Net book value
	At 28 February 2025				16,873
	At 28 February 2024				9,445


4	Debtors		2025		2024
£				£

	Trade debtors		-		-


5	Creditors: amounts falling due within one year		2025		2024
£				£

	Trade creditors		23,160		14,891
	Corporation tax		-		-
	Other taxes and social security costs		164		164
	Other creditors		4,843		4,843
			28,167		19,898


6	Other information

	Mediprop Limited is a private company limited by shares and incorporated in England. Its registered office is:
	277 Stockport Road
	Ashton U Lyne
	Lancashire
	OL7 0NT